3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
5
Not yet recruiting
1
Enrolling by invitation
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
162
Neoplasms
119
Carcinoma, Non-Small-Cell Lung
93
Prostatic Neoplasms
86
Colorectal Neoplasms
86
Lung Neoplasms
78
Leukemia, Myeloid, Acute
54
Carcinoma, Hepatocellular
53
Pancreatic Neoplasms
46
Neoplasm Metastasis
44
Multiple Myeloma
39
Recurrence
36
Triple Negative Breast Neoplasms
32
Squamous Cell Carcinoma of Head and Neck
29
Precursor Cell Lymphoblastic Leukemia-Lymphoma
29
Ovarian Neoplasms
29
Melanoma
29
Brain Neoplasms
29
Glioblastoma
28
Uterine Cervical Neoplasms
27
Stomach Neoplasms
27
Head and Neck Neoplasms
27
Rectal Neoplasms
25
Small Cell Lung Carcinoma
23
Carcinoma, Renal Cell
22
Glioma
21
Sarcoma
19
Lymphoma, B-Cell
19
Endometrial Neoplasms
19
Lymphoma, Follicular
18
Interventions
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Cytokine Release Syndrome
×
90 days
×
Clear all
NCT07609940
2026-05-27
POPLIN
Regeneron Pharmaceuticals
Phase 4
Not yet recruiting
30 enrolled